Articles related to Endocrinology, Diabetes, Metabolism

A recent Danish cohort study reveals that older adults (≥75 years) may experience a more pronounced LDL-C reduction with low- to moderate-intensity statins than their younger counterparts. This finding emphasizes the need to consider age when prescribing statin therapy.

The recent systematic review comparing obesity management drugs highlights semaglutide and phentermine/topiramate as the most effective in weight loss and waist circumference reduction at 12 months. Explore the full study to understand the comparative efficacy and safety of these medications in obesity treatment.

The potential shortage of Saxenda (liraglutide) through 2023 underscores the importance of monitoring the availability of this weight management drug. Physicians should be aware of this situation and consider alternative options if necessary.

Explore the study’s analysis, which also uncovers potential cardiovascular benefits associated with SGLT2i initiation among patients with gout and type 2 diabetes.

Brenzavvy, the latest addition to the diabetes treatment landscape, promises a cost-effective approach to managing type 2 diabetes. Discover how this newly approved drug could redefine the treatment paradigm for patients.

Orforglipron is a novel once-daily oral GLP-1 receptor agonist that has been shown to be effective in reducing weight in adults with obesity or overweight. Further studies are needed to establish whether the health benefits seen with injectable GLP-1 receptor agonists are shared by orforglipron.